open access

Vol 67, No 5 (2017)
Review paper
Published online: 2018-02-22
Get Citation

Current possibilities of peri-operative evaluation of the radicality of primary tumour resection in breast cancer patients treated with BCT (breast conserving treatment)

Tomasz Nowikiewicz, Wojciech Zegarski
·
Nowotwory. Journal of Oncology 2017;67(5):285-291.

open access

Vol 67, No 5 (2017)
Review article
Published online: 2018-02-22

Abstract

In accordance with the current standards of treatment of breast cancer patients, the application of breast conserving treatment (BCT) requires a radical resection of the tumour and post-operative radiotherapy. This means the necessity of obtaining tumour-free primary resection margins, i.e. without the presence of cancer tissue. In spite of the cor­rect pre-operative diagnostic process and appropriate surgical treatment, in about 20–30% BCT cases, the tumour resection turns out to be not radical. The necessity of performing another surgery leads to the prolongation of the overall operative time and increases costs.

A histopathological evaluation of the margin of the primary tumour resection performed on an immediate basis is not a standard procedure in patients undergoing BCT. In spite of the definite limitations of this method, its application may decrease the overall rate of revision surgeries. The paper discusses some other currently available possibilities of perioperative evaluation of the radicality of primary tumour resection in breast cancer patients treated with BCT.

Abstract

In accordance with the current standards of treatment of breast cancer patients, the application of breast conserving treatment (BCT) requires a radical resection of the tumour and post-operative radiotherapy. This means the necessity of obtaining tumour-free primary resection margins, i.e. without the presence of cancer tissue. In spite of the cor­rect pre-operative diagnostic process and appropriate surgical treatment, in about 20–30% BCT cases, the tumour resection turns out to be not radical. The necessity of performing another surgery leads to the prolongation of the overall operative time and increases costs.

A histopathological evaluation of the margin of the primary tumour resection performed on an immediate basis is not a standard procedure in patients undergoing BCT. In spite of the definite limitations of this method, its application may decrease the overall rate of revision surgeries. The paper discusses some other currently available possibilities of perioperative evaluation of the radicality of primary tumour resection in breast cancer patients treated with BCT.

Get Citation

Keywords

breast cancer, breast conserving treatment (BCT), surgical margins, perioperative evaluation, gross clinical evaluation, microscopic evaluation

About this article
Title

Current possibilities of peri-operative evaluation of the radicality of primary tumour resection in breast cancer patients treated with BCT (breast conserving treatment)

Journal

Nowotwory. Journal of Oncology

Issue

Vol 67, No 5 (2017)

Article type

Review paper

Pages

285-291

Published online

2018-02-22

Page views

839

Article views/downloads

756

DOI

10.5603/NJO.2017.0047

Bibliographic record

Nowotwory. Journal of Oncology 2017;67(5):285-291.

Keywords

breast cancer
breast conserving treatment (BCT)
surgical margins
perioperative evaluation
gross clinical evaluation
microscopic evaluation

Authors

Tomasz Nowikiewicz
Wojciech Zegarski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl